WO2004112806A8 - Composition for treating or preventing neural disorders - Google Patents

Composition for treating or preventing neural disorders

Info

Publication number
WO2004112806A8
WO2004112806A8 PCT/CA2004/000951 CA2004000951W WO2004112806A8 WO 2004112806 A8 WO2004112806 A8 WO 2004112806A8 CA 2004000951 W CA2004000951 W CA 2004000951W WO 2004112806 A8 WO2004112806 A8 WO 2004112806A8
Authority
WO
WIPO (PCT)
Prior art keywords
composition
treating
neural disorders
preventing neural
preventing
Prior art date
Application number
PCT/CA2004/000951
Other languages
French (fr)
Other versions
WO2004112806A1 (en
Inventor
Binh Nguyen-Quoc
Original Assignee
Canada Changmin Nutraceutique
Binh Nguyen-Quoc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canada Changmin Nutraceutique, Binh Nguyen-Quoc filed Critical Canada Changmin Nutraceutique
Publication of WO2004112806A1 publication Critical patent/WO2004112806A1/en
Publication of WO2004112806A8 publication Critical patent/WO2004112806A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a method of use and composition containing antler extract as active component in the prevention or treatment of nerve cells or nervous system diseases. Particularly the composition of the invention is useful in treating or preventing nerve cells of or against degenerescence and oxidation.
PCT/CA2004/000951 2003-06-26 2004-06-25 Composition for treating or preventing neural disorders WO2004112806A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48247603P 2003-06-26 2003-06-26
US60/482,476 2003-06-26

Publications (2)

Publication Number Publication Date
WO2004112806A1 WO2004112806A1 (en) 2004-12-29
WO2004112806A8 true WO2004112806A8 (en) 2005-03-10

Family

ID=33539348

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2004/000951 WO2004112806A1 (en) 2003-06-26 2004-06-25 Composition for treating or preventing neural disorders

Country Status (1)

Country Link
WO (1) WO2004112806A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102781455B (en) 2010-01-26 2014-06-04 干细胞旋转股份公司 Cell homogenate from stem cells derived from growing deer antlers, a method of obtaining it and its use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2075052B (en) * 1980-04-25 1983-09-21 Ting Chung Antler brandy
BE905763A (en) * 1986-11-17 1987-03-16 Bougard Marianne Using deer antler material to improve circulatory disorders - by powdering or extracting with e.g. alcohol
CN1090765A (en) * 1993-02-12 1994-08-17 张祥德 " Shouwuchangchunbao " medicine containing polygonum multiflorum and preparation method thereof
CN1091014A (en) * 1993-02-13 1994-08-24 李�浩 Treatment is in the Chinese patent medicine of the chronic schizophrenia of decline state
CN1093591A (en) * 1993-04-06 1994-10-19 邹积生 Capsule for strengthening sexual function of men
CN1104095A (en) * 1993-12-24 1995-06-28 霍玉书 Pilose antler growth-factor preparation and technology for making it
CN1055248C (en) * 1996-12-19 2000-08-09 贾广田 Traditional Chinese prescription medicine for treatment of cerebral paralysis disease
CN1158743A (en) * 1997-03-13 1997-09-10 耿卫华 Chinese herbal medicine composition for curing cerebral paralysis and apoplexy
CN1061253C (en) * 1997-12-05 2001-01-31 张子申 Magistral medicine for treating bone disease such as osteoporosis, and method for preparing same
CN1063650C (en) * 1997-12-08 2001-03-28 阎俊峰 Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method
CN1205220A (en) * 1998-04-27 1999-01-20 杨发鑫 Capsule for nourishing kidney and strengthening Yang
CN1184303C (en) * 2000-03-21 2005-01-12 王振山 Wine for mourishing blood, heart and brain
CN1102399C (en) * 2000-06-09 2003-03-05 张庆玉 Antilipemic blood circulation promoting xueluofu capsale
CN1204908C (en) * 2001-09-04 2005-06-08 刘现峰 Deafness and tinnitus treating Chinese medicine and its prepn
CN1339316A (en) * 2001-10-19 2002-03-13 戚晓峰 Medicine for curing child brain paralysis

Also Published As

Publication number Publication date
WO2004112806A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
WO2002044187A3 (en) Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
WO2006040688A3 (en) Inhibitors of acetylcholinesterase for treating skin diseases
WO2006009975A3 (en) Histamine to treat disorders affecting muscle function
WO2009033027A3 (en) Suppression of scn9a gene expression and/or function for the treatment of pain
WO2004006906A3 (en) Methods for the treatment of neoplasms
WO2005039504A3 (en) Compounds and methods for treating toll-like receptor 2-related diseases and conditions
WO2005014525A3 (en) Bi-aryl compound having immunosuppressive activity
WO2004110376A3 (en) Ccr-2 antagonists for treatment of neuropathic pain
WO2002045749A3 (en) Methods for stimulating nervous system regeneration and repair by inhibition phosphodiesterase type 4
WO2007098091A3 (en) Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
WO2007098089A3 (en) Treatment of hyperproliferative diseases with methotrexate n-oxide and analogs
WO2004096216A3 (en) Use of a topical medicament comprising riluzole
WO2006098603A3 (en) Composition comprising isoorientin for suppressing histamine
WO2008157791A3 (en) Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones
TNSN06403A1 (en) 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
WO2004060289A3 (en) Use of purslane to treat facial wrinkles
WO2000066068A3 (en) Method for inducing growth and enhancing survival of nervous tissue
WO2008086452A3 (en) Treatment and prevention of alzheimer's disease
WO2007035722A3 (en) Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
WO2005082375A3 (en) Treatment of interstitial cystitis with vitamin d compounds
AU2001266289A1 (en) 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury
WO2000057865A3 (en) Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
ATE410172T1 (en) USE OF AN ANALOG OF VITAMIN D3 FOR THE TREATMENT OF AUTOIMMUNE DIABETES
WO2006101910A3 (en) Peptide compounds and methods of using peptide compounds to treat conditions affecting the cardiac, pulmonary, and nervous systems

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WR Later publication of a revised version of an international search report
122 Ep: pct application non-entry in european phase